NCT06955325 2025-05-06
UPLIFT
The First Affiliated Hospital of Guangzhou Medical University
Phase 3 Not yet recruiting
Clinical Trials
4 trialsNCT06779539 2025-01-17
Neoadjuvant Ensartinib in ALK Positive Resectable Stage II to III Non-Small Cell Lung Cancer
West China Hospital
Phase 2 Not yet recruiting
NCT06780839 2025-01-17
Adjuvant Treatment of ALK-positive Non-small Cell Lung Cancer with Ensartinib Guided by MRD
Peking University Cancer Hospital & Institute
Phase 2 Not yet recruiting
NCT05186506 2022-01-11
A Study Comparing Ensatinib Versus Platinum-Based Chemotherapy as Adjuvant Treatment for Stage II-IIIA ALK -Positive Non-Small Cell Lung Cancer
Sichuan University
Phase 2 Not yet recruiting